The Effect of ShotBlocker on Pain and Satisfaction During Measles-Rubella-Mumps Vaccination

Not Applicable

Completed

• Conditions: Pain

• Registration Number: NCT06762938
• Lead Sponsor: Yuzuncu Yıl University

Brief Summary

Objective The aim of this study was to evaluate the effects of ShotBlocker administration during measles-mumps-rubella (MMR) vaccination on infants' pain level and mothers' satisfaction.

Method. The study was conducted in a Family Health Center affiliated to the Public Health Directorate of a province in eastern Turkey between August and October 2024 using a randomized controlled experimental design. The study sample consisted of 60 infants who received MMR vaccination (ShotBlocker group: n = 30, control group: n = 30). Infants in the ShotBlocker group received ShotBlocker before vaccine injection, while infants in the control group received only routine vaccine injection. Infant information form, FLACC pain scale and Newcastle Satisfaction with Nursing Care Scale were used for data collection. Ethical principles were followed throughout the study.

Detailed Description

Not available

Study Timeline

• Study Start: 2024-08-01
• Primary Completion: 2024-11-20
• Study Completion: 2024-11-30
• Study First Submitted: 2024-12-31
• Status Verified: 2025-01
• Study First Submitted QC: 2025-01-07
• Last Update Submitted: 2025-01-07
• Study First Posted: 2025-01-08
• Last Update Posted: 2025-01-08

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 60

Inclusion Criteria

• He's 12 months old,
• MMR vaccine will be administered,
• growth-development is normal,
• no analgesic medication was given during the day,
• at least high school graduate
• mothers who volunteered to participate in the study

Exclusion Criteria

• Neurological disease,
• a chronic disease,
• allergy (egg allergy)
• infants with symptoms of hyperthermia

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: CROSSOVER

Primary Outcome Measures

Name	Time	Method
Face, Legs, Activity, Crying, Consolability Pain Scala	pre-test post-test (approximately three months)	min-max (0-10), lower score means better result, reduce scale scores

Trial Locations

Locations (1)

Van Yüzüncü Yıl University; 🇹🇷 VAN, Tuşba, Turkey